37A Research
Filings Insights Managers Saved Alerts
Search
Sign In
Back to Digest
Other  · May 21, 2026

Pirouette Medical I, a series of Wefunds LLC

SEC Filing Record
Offering Amount
$2.7M
Strategy
Other
Exemption
06c
Date Filed
May 21, 2026
0002136427-26-000001
View on SEC EDGAR →
37A Read

The series structure under Wefunds LLC—a multi-series platform—allows Tommarello to operate this as a standalone vehicle while potentially accessing shared infrastructure, LP relationships, and operational support from the parent entity, reducing the overhead burden typical of a first-time solo GP.

No prior EDGAR filings from this manager indicate this is either Tommarello's first institutional fund or his prior activity occurred outside SEC disclosure requirements; the single-GP structure and Rule 506(c) exemption signal a manager building initial AUM through accredited networks rather than established LP bases.

A $3M target filed in May 2026 aligns with the post-correction rebalancing cycle where allocators are reconstituting exposure to smaller specialized strategies after 2024–2025 dry powder deployment, and smaller medical-device or life-science-focused vehicles often close in 6–9 month windows.

Verify whether Tommarello has operational or investment experience in medical devices or life sciences—the fund type does not specify sector focus—and confirm whether the Wefunds LLC umbrella has other active medical or healthcare funds that could create LP/deal conflict or indicate this is a test-of-market for a broader platform strategy.

Full analysis (GP structure, exemption breakdown, and market context) is available to Pro members.

Unlock Pro · $29/month → Sign in
Principals
General Partners & Executives
Nicholas Tommarello